Any biopharma L/S funds that take people out of undergrad?

I am a undergrad really interested in biopharma long short investing and hoping to skip to buyside out of college. Besides the big pod shops, are there any specific biopharma funds I should be targeting? I've heard of deerfield management but pretty sure theyve only taken people out of UG from a diversity program.

32 Comments
 
I'm an AI bot trained on the most helpful WSO content across 17+ years.
 
Most Helpful

He watched Marin Shkreli on YouTube! Undergrad English literature

 

Wondering if you still think this is still true for an undergrad with a lot of experience (eg BioE undergrad, published papers, experience in Biopharma BD, following market constantly)

 
Funniest

"hurr durr look at me i can understand ORR in cancer trials because i am big monkey know how to fix bones"

i hope u understand PoS and NPV before u go bragging to your ortho friends about future earnings

 

Biotech hiring is unstructured at all levels. Some funds require you have a graduate degree while others explicitly don’t care (e.g. EcoR1). Your best shot is to cold email different funds. Not unattainable out of undegrad, but it’s rare.

FWIW - some of the biotech dedicated roles you’re referring to have hired out of undergrad these last 2-3 years; just do a quick LinkedIn search, and you’ll see a lot from UPenn. These are LO and/or high quality funds that rarely hire. Common denominator seems to be some dual track of Finance + Bio with research experience and relevant internships.

 

Dicta velit rerum rerum voluptatibus aut ducimus tempore. Tempora quia facilis illum nulla. Qui voluptatem qui quisquam consequatur eveniet molestias totam eveniet. Placeat maxime ipsum esse incidunt et quis.

 

Beatae qui iste hic odio omnis aliquid et. Deserunt excepturi repellendus molestiae dolorem illum veniam quod qui. Dolores eveniet et quis earum accusantium nisi. Laudantium iure ex est fugit et minima. Est culpa architecto rerum animi. Nesciunt suscipit vel atque amet expedita maxime.

Ex quasi ut temporibus similique sapiente. Molestias quam hic aut inventore est corrupti. Ex rerum ipsa exercitationem amet deserunt. Voluptas atque nemo inventore ratione velit officiis placeat. Quia consequatur vel aut expedita. Incidunt ut aut eum illum optio velit.

Career Advancement Opportunities

October 2026 Hedge Fund

  • Point72 99.0%
  • D.E. Shaw 98.0%
  • AQR Capital Management 97.0%
  • Citadel Investment Group 96.0%
  • Magnetar Capital 95.0%

Overall Employee Satisfaction

October 2026 Hedge Fund

  • Magnetar Capital 99.0%
  • D.E. Shaw 98.0%
  • Blackstone Group 97.0%
  • Citadel Investment Group 96.0%
  • Two Sigma Investments 94.9%

Professional Growth Opportunities

October 2026 Hedge Fund

  • AQR Capital Management 99.0%
  • Point72 98.0%
  • D.E. Shaw 97.1%
  • Citadel Investment Group 96.1%
  • Magnetar Capital 95.1%

Total Avg Compensation

October 2026 Hedge Fund

  • Portfolio Manager (9) $1,648
  • Vice President (27) $464
  • Director/MD (12) $355
  • NA (9) $320
  • Engineer/Quant (83) $287
  • 3rd+ Year Associate (26) $284
  • Manager (4) $282
  • 2nd Year Associate (32) $253
  • 1st Year Associate (76) $193
  • Analysts (235) $177
  • Intern/Summer Associate (29) $145
  • Junior Trader (5) $102
  • Intern/Summer Analyst (276) $95
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Secyh62's picture
Secyh62
99.0
4
kanon's picture
kanon
99.0
5
DrApeman's picture
DrApeman
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
Betsy Massar's picture
Betsy Massar
98.9
9
GameTheory's picture
GameTheory
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”